View Article

  • A COMPREHENSIVE REVIEW ON PICRORHIZAKURROA (KUTKI): PHYTOCHEMISTRY, PHARMACOLOGY AND THERAPEUTIC POTENTIAL

  • 1Asst. Prof., Department of Pharmaceutics, Rupesh Badhan Institute of Pharmacy, Pimpalner (MH) India
    3Asst. Prof., Department of Pharmacology, SPH College of Pharmacy, Malegaon (MH) India
    2, 4Students at Rupesh Badhan Institute of Pharmacy, Pimpalner (MH) India
    5Asst. Prof., Department of Pharmaceutics
    6Student at Rupesh Badhan institute of Pharmacy, Pimpalner, (MH) India
     

Abstract

Picrorhiza kurroa is a high-altitude Himalayan medicinal species extensively utilized in Ayurvedic practice and increasingly investigated in contemporary pharmacological research. The plant is a rich source of bioactive constituents, particularly iridoid glycosides such as Picroside I, Picroside II, and Kutkin, along with diverse secondary metabolites including phenolics, flavonoids, alkaloids, and terpenoids. These compounds collectively contribute to its wide-ranging biological properties. Experimental evidence indicates that P. kurroa demonstrates multiple pharmacological effects, notably hepatoprotective, antioxidant, anti-inflammatory, immune regulatory, antimicrobial, antidiabetic, cardioprotective, and anticancer activities. Its role in liver protection is particularly significant, with reported efficacy in conditions such as jaundice, hepatitis, and non-alcoholic fatty liver disease through mechanisms involving oxidative balance regulation, suppression of inflammatory mediators, and modulation of intracellular signaling pathways. Ethno medicinal applications of the plant include its use in managing digestive disturbances, respiratory ailments, dermatological conditions, febrile states, and metabolic imbalances. Traditional descriptions also highlight its function as a hepatic tonic, mild laxative, and detoxifying agent. Recent scientific investigations provide supportive evidence for many of these uses, suggesting its potential integration into modern therapeutic strategies. Despite its pharmacological importance, it faces a significant decline in natural populations due to over harvesting, ecological pressures, and slow growth characteristics. This necessitates the implementation of conservation measures, development of sustainable cultivation practices, and application of biotechnological approaches to ensure consistent production of its active constituents. In summary, it represents a pharmacologically important medicinal plant with substantial therapeutic promise. Further studies focusing on molecular targets, clinical validation, quality control, and safety assessment are essential to facilitate its translation into evidence-based medicinal applications.

Keywords

Picrorhiza kurroa; iridoid glycosides; hepato-protective activity; antioxidant; traditional medicine; endangered medicinal plants.

Introduction

Medicinal plants have been an integral component of traditional health care systems since ancient times, forming the foundation of various systems such as Ayurveda, Unani, and Traditional Chinese Medicine. Among these, Picrorhiza kurroa Royle ex Benth., commonly known as Kutki, occupies a prominent position due to its extensive therapeutic applications and well-documented efficacy in liver-related disorders. Belonging to the family Plantaginaceae (formerly Scrophulariaceae), P. kurroa is a small perennial herb predominantly found in the alpine Himalayan regions of India, Nepal, and Tibet, typically at altitudes ranging from 3000 to 5000 meters. It has been widely used in Ayurvedic medicine for centuries, where it is classified as a “Rasayana” herb known for its rejuvenating, detoxifying, and disease-preventive properties. Classical Ayurvedic texts describe its use in treating liver disorders (Yakrit Vikara), fever (Jwara), respiratory diseases, skin ailments, and digestive disturbances. Its rhizomes are primary medicinal part and are characterized by an intensely bitter taste, which is indicative of the presence of active phyto-constituents. Due to its hepato-protective, anti-inflammatory, and immune-modulatory properties, it has gained significant attention not only in traditional medicine but also in modern pharmacological research. In recent decades, there has been a growing interest in plant-based therapeutics due to the increasing prevalence of chronic diseases, adverse effects associated with synthetic drugs, and the global shift towards natural and holistic healthcare approaches. Liver diseases, including hepatitis, cirrhosis, and non-alcoholic fatty liver disease, represent a major global health burden, and there is a continuous search for effective and safe hepatoprotective agents. In this context, P. kurroa has emerged as a promising candidate owing to its ability to protect liver cells from toxic damage, enhance bile secretion, and regulate metabolic functions. Scientific studies have demonstrated that extracts of Kutki can significantly reduce liver enzyme levels, improve antioxidant status, and prevent histopathological changes in hepatic tissues. The pharmacological potential of P. kurroa is largely attributed to its rich phytochemical composition. The plant is particularly known for its iridoid glycosides, such as picroside-I, picroside-II, andkutkoside, collectively referred to as “kutkin.” These compounds are considered as the principal bioactive markers responsible for many of its therapeutic effects. In addition iridoids, Kutki contains a wide range of secondary metabolites including flavonoids, phenolic compounds, terpenoids, alkaloids, glycosides, and cucurbitacins. These phytochemicals exhibit synergistic effects, contributing to the plant’s antioxidant, anti-inflammatory, antimicrobial, antidiabetic, and anticancer activities. The presence of such a diverse array of bioactive molecules makes P. kurroa an important subject for phytochemical and pharmacological investigations. Modern research has extensively explored the pharmacological properties of P.kurroa through in vitro and in vivo studies. Among its various biological activities, hepato protective effects are the most extensively studied and validated. The plant has been shown to exert protective effects against chemically induced liver damage caused by agents such as carbon tetrachloride, paracetamol, and alcohol. Its mechanism of action involves the modulation of oxidative stress, inhibition of lipid peroxidation, enhancement of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase, and regulation of inflammatory mediators. Furthermore, Kutki has demonstrated immunomodulatory properties by enhancing both humoral and cell-mediated immune responses, making it beneficial in conditions involving immune dysfunction. Apart from liver protection, P.kurroa exhibits a broad spectrum of pharmacological activities. Its antioxidant properties help in neutralizing free radicals and preventing cellular damage, thereby playing a role in the prevention of chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions. The anti-inflammatory activity of Kutki is associated with the inhibition of pro-inflammatory cytokines and enzymes such as cyclo-oxygenase (COX) and lipo-oxygenase (LOX). Additionally, studies have reported its antidiabetic potential through the regulation of blood glucose levels and improvement of insulin sensitivity. Emerging evidence also suggests its role in cancer prevention and therapy by inducing apoptosis and inhibiting tumor growth in various experimental models. Despite its significant medicinal importance, P. kurroa faces serious threats due to over harvesting, habitat destruction, and its slow natural regeneration rate. The increasing demand for Kutki in pharmaceutical and herbal industries has led to its overexploitation in the wild, resulting in a decline in its natural populations. Consequently, the plant has been categorized as an endangered species in several regions. This highlights the urgent need for conservation strategies, including in situ and ex situ conservation, sustainable harvesting practices, and the development of cultivation techniques. Biotechnological approaches such as tissue culture and micropropagation have also been explored to ensure the large-scale production and preservation of this valuable medicinal plant. In addition to conservation challenges, there are several issues related to the standardization, quality control, and clinical validation of P. kurroa-based formulations. Variability in phytochemical composition due to geographical, environmental and genetic factors can affect the efficacy and safety of herbal products. Therefore, the development of standardized extracts, identification of reliable biomarkers, and implementation of good agricultural and collection practices (GACP) are essential to ensure consistency and quality.

Botanical Description and Morphology

Picrorhiza kurroa Royle ex Benth., commonly known as Kutki, is a perennial, rhizomatous medicinal herb belonging to the family Plantaginaceae. It is an important high-altitude Himalayan species recognized for its pharmacological relevance and distinctive morphological adaptations to extreme ecological conditions. A detailed botanical and morphological characterization is essential for accurate taxonomic identification, pharmacognostic evaluation, and quality control of crude drug materials used in herbal formulations.

Figure 1: Rhizome of Kutki

  • Kingdom: Plantae
  • Division: Angiosperms
  • Class: Eudicots
  • Order: Lamiales
  • Family: Plantaginaceae
  • Genus: Picrorhiza
  • Species: Picrorhizakurroa Royleex Benth.

Synonyms: Picrorhiz as crophularii flora (oftenc on fused species)

Common names: Kutki (Hindi), Katuka (Sanskrit), Hellebore (English, loosely used)

  1. Geographical Distribution and Habitat

P. kurroa is endemic to the north-western Himalayan region, including India (Jammu & Kashmir, Himachal Pradesh, Uttarakhand), Nepal, and Tibet. Itthrivesa televation sranging from 3000 to 5000 m above sea level, primarily in alpine and subalpine zones.

The plant typically grows in:

  • Moist rocky crevices
  • Alpine slopes and grasslands
  • Glacial moraines and shaded, humid habitats

Its ecological niche is characterized by low temperatures, high UV exposure, short growing seasons, and nutrient-poor soils, which significantly influence its morphological and biochemical traits.

  1. Habit and General Morphology

P. kurroa is a dwarf, stoloniferous, perennial herb, generally attaining a height of 5–15 cm. The plant exhibits a prostrate or semi-erect growth habit, with leaves arranged in a basal rosette and flowering shoots arising directly from the rhizome. Its perennial nature is maintained through an underground rhizome to us system, enabling survival during prolonged snow cover and freezing conditions.

  1. Underground Parts (Rhizome and Roots)
    1. Rhizome

The rhizome of Picrorhiza kurroa represents the most diagnostically important and pharmacologically active part of the plant. It is well developed and exhibits distinct morphological features useful for identification and quality assessment. The rhizome is creeping, stoloniferous, and profusely branched, typically cylindrical to sub-cylindrical in form. Its length generally ranges from 2 to 10 cm, with a diameter of approximately 0.5–1.5 cm. Externally, it appears brown to grey, whereas the internal tissue is whitish to pale in color. The surface is characterized by conspicuous longitudinal wrinkles along with clearly visible annulations formed by leaf scar rings, giving it a rough and uneven texture. When broken, the rhizome shows a short and brittle fracture. Organoleptically, it possesses a distinctly bitter taste and a characteristic odor. Functionally, the rhizome acts as a storage organ, accumulating a high concentration of bioactive compounds, particularly iridoid glycosides such as Picroside I and Picroside II, which contribute to its therapeutic properties. In addition, it plays a vital role in vegetative propagation, enabling the plant to spread and survive under harsh environmental conditions.

    1. Roots

In Picrorhiza kurroa, the root system is composed of adventitious, fibrous roots that originate from the nodes of the rhizome. These roots are slender, extensively branched, and adapted to penetrate rocky and compact substrates typical of high-altitude environments. Functionally, they provide effective anchorage to the plant while also facilitating the absorption of water and nutrients under conditions where soil fertility is limited.

Aerial Parts

    1. Stem

In Picrorhiza kurroa, the aerial stem is highly reduced and not prominently developed. The visible shoot system is mainly characterized by a basal arrangement of leaves forming a rosette close to the ground surface. In addition, a leafless flowering scape emerges directly from the rhizome, bearing the reproductive structures.

    1. Leaves

The leaves of Picrorhiza kurroa are morphologically distinctive and serve as reliable diagnostic features for identification. They are arranged in a radical (basal) rosette and are simple in structure, typically sessile or occasionally subsessile. Leaf blades vary in shape from oblong and lanceolate to spatulate, measuring approximately 2–10 cm in length and 1–3 cm in width. The margins are serrate to crenate, with apices ranging from acute to obtuse and a gradually tapering base. The surface is smooth, glabrous, and slightly coriaceous, while venation is reticulate. Leaves exhibit a characteristic dark green coloration. These leaves display xeromorphic adaptations, including a relatively reduced surface area and a somewhat leathery texture, which help limit water loss and enhance survival under high-altitude environmental stress.

6. Reproductive Morphology

6.1 Inflorescence

The inflorescence is a terminal spike borne on an erect, slender, and leafless scape arising from the rhizome. The scape typically attains a length of 5–15 cm and supports a compact cluster of sessile flowers arranged densely along the axis.

6.2 Flowers

The flowers are bisexual, zygomorphic, and bracteate, and are relatively small, measuring about 5–8 mm in size. Their coloration varies from pale blue to violet or occasionally white.

Floral structure includes:

  • Calyx: Five-lobed and persistent
  • Corolla: Tubular and distinctly bilabiate
  • Androecium: Four stamens (didynamous), attached to the corolla (epipetalous)
  • Gynoecium: Bicarpellary and syncarpous
  • Ovary: Superior and bilocular
  • Style: Single
  • Stigma: Bifid

The flowering phase generally occurs between June and August. The floral organization is consistent with characteristics typical of the order Lamiales, supporting insect-mediated pollination mechanisms.

6.3 Fruit

The fruit is a septicidal capsule, typically ovoid to ellipsoid in shape. It dehisces longitudinally to release the seeds and is relatively small in size, usually only a few millimeters in length.

6.4 Seeds

Seeds are numerous, minute, and vary from oblong to irregular in shape. Their surface may be smooth or slightly reticulate, and they are generally brown in color. Under natural conditions, seed viability is often low, which contributes to the slow regeneration and limited propagation of the species.

7. Microscopic and Pharmacogenetic Features

Microscopic examination of the rhizome of Picrorhiza kurroa reveals well-defined tissue organization. The outermost layer consists of a multilayered cork (phellem) that provides protection. Beneath this lies a cortex composed of parenchymatous cells, many of which contain abundant starch grains. The vascular system is represented by scattered vascular bundles containing both xylem and phloem elements, while medullary rays are also present. Cellular inclusions commonly observed include starch granules, glycosidic substances, and occasionally calcium oxalate crystals, all of which are important for pharmacognostic identification and standardization.

Figure 2: Transverse section of kutki

Table 1: Diagnostic and Distinguishing Features

Sr. No.

Feature Category

Diagnostic Characteristics of Picrorhiza kurroa

Distinguishing Significance

1

Habit

Small, perennial, rhizomatous herb (5–15 cm height)

Differentiates from larger herbaceous adulterants

2

Habitat

Alpine  Himalayas (3000–5000 m altitude),moist rocky slopes

Unique ecological

Niche helps in identification

3

Rhizome (Macroscopy)

Creeping, cylindrical, branched

Key identifying feature in crude drug form

4

Rhizome Color

Brown to grey externally; whitish internally

Useful  for

Distinguishing from darker adulterants

5

Taste

Intensely bitter

Characteristic organoleptic property due to iridoid glycosides

6

Leaf Arrangement

Radical (basal rosette)

Helps differentiate from plants with cauline leaves

7

Leaf Morphology

Oblong/lanceolate, serrated            margins, glabrous surface

Distinct morphological marker

8

Stem

Reduced or absent aerial stem

Unique adaptation to alpine conditions

9

Inflorescence

Terminal spike

Differentiates from raceme or

panicle-bearing species

10

Flowers

Small,  pale

blue/violet,

Typical of Lamiales but distinct in combination with other traits

11

Fruit Type

Ovoid capsule

Supports taxonomic classification

12

Seeds

Numerous, minute, brown

Indicates reproductive pattern

13

Cork (Microscopy)

Multilayered,

Diagnostic for rhizome identification

14

Cortex

Parenchymatous with abundant starch grains

Indicates storage function

16

Starch Grains

Simple and compound, abundant

Important pharmacognostic marker

17

Calcium Oxalate Crystals

Rare or absent

Differentiates from crystal-rich adulterants

18

Active Constituents

Picroside-I, Picroside-II (kutkin complex)

Chemical marker for authentication

19

Odor

Characteristic, slightly aromatic

Supports organoleptic evaluation

Ecological and Adaptive Significance

Picrorhiza kurroa Royle ex Benth., a perennial medicinal herb belonging to the family Plantaginaceae, is an ecologically specialized species endemic to the alpine and subalpine zones of the Himalayas. It occurs at altitudes ranging from 3000 to 5000 m above sea level, where it thrives under extreme environmental constraints including low temperature, high ultraviolet radiation, hypoxic conditions, and a short growing season. The ecological amplitude of this species reflects a suite of morphological, physiological, and biochemical adaptations that collectively ensure its survival and persistence in fragile mountain ecosystems. Furthermore, the species contributes to microhabitat formation, facilitating the establishment of other plant taxa and thus supporting localized biodiversity. These ecological functions are particularly significant in Himalayan ecosystems, which are highly sensitive to environmental perturbations and climate variability. The adaptive strategies of P. kurroa are evident in its morphological features, including adwarf growth habit and a basal rosette leaf arrangement. The setraits minimize exposure to desiccating winds and reduce transpirational water loss, which is critical under conditions of limited water availability due to frozen soils. The rhizomatous growth pattern not only enables vegetative propagation but also acts as a survival mechanism during prolonged periods of dormancy induced by snow cover. Such adaptations ensure perennial regeneration even under adverse climatic conditions. At the physiological and biochemical levels, P. kurroa synthesizes a diverse array of secondary metabolites, particularly iridoid glycosides such as  picroside I and II, along with kutkoside and apocynin. These compounds playa dual role in ecological adaptation and defense. They function as protective agents against herbivory and pathogenic attacks while also mitigating oxidative stress induced by high UV radiation and low temperatures. The accumulation of phenolic and antioxidant compounds is a well-documented adaptive response in alpine plants and is extensively studied within the domain of Phytochemistry. Reproductively, P. kurroa exhibits both sexual and asexual modes of propagation, which is a critical adaptive feature in environments where pollinator activity is limited and unpredictable. In terms of ecosystem functioning, P. kurroa contributes to nutrient cycling and supports pollinator interactions during the limited growing season. Its presence within alpine plant communities enhances structural diversity and ecological complexity. However, despite its ecological significance, the species is under severe threat due to overexploitation for its medicinal value, habitat degradation, and the impacts of climate change. The decline of P.kurroa populations poses a risk to the stability of alpine ecosystems and the loss of valuable genetic resources. Conservation efforts are therefore imperative and have been advocated by global organizations such as the International Union for Conservation of Nature. Strategies including in situ conservation, sustainable harvesting practices, and large-scale cultivation are recommended to mitigate the risk of extinction and to preserve its ecological and pharmacological importance.

Geographical Distribution

Picrorhiza kurroa Royle ex Benth., a perennial herb of the family Plantaginaceae, exhibits a highly restricted and specialized geographical distribution confined primarily to the alpine and subalpine regions of the Himalayas. The species typically occurs at altitudinal ranges between 3000 and 5000 m above sea level, where it is adapted to cold, humid, and ecologically fragile environments characterized by steep slopes, rocky substrates, and prolonged snow cover. From a biogeographical standpoint, P. kurroa is distributed across several countries in South Asia, including India, Nepal, Bhutan, and Pakistan. This distribution aligns with the Himalayan biodiversity hotspot, which is recognized for its high species richness and endemism. With in this range, the species occupies specific ecological niches such as alpine meadows, moist rock crevices, and glacial stream banks, indicating its strong dependence on microclimatic and edaphic factors. In India, P. kurroa is predominantly found in the western and central Himalayan regions, particularly in the states of Jammu and Kashmir, Himachal Pradesh, and Uttarakhand. These regions provide optimal environmental conditions, including low temperatures, high relative humidity, and well-drained soils enriched with organic matter. The species is often associated with north-facing slopes and shaded habitats, which help mitigate water loss and ther mal stress, thereby enhancing its survival in extreme alpine climates. The distribution pattern of P. kurroa is inherently fragmented and patchy, largely due to its narrow ecological amplitude and specialized habitat requirements. Population density within its natural range is typically low, and occurrences are often localized to specific microhabitats that provide adequate moisture and protection from environmental stressors. Such discontinuous distribution is further exacerbated by limited seed dispersal mechanisms and dependence on short growing seasons, which restrict large-scale colonization. Environmental factors such as temperature gradients, precipitation patterns, soil composition, and snow cover duration play a crucial role in determining the spatial distribution of P. kurroa. Additionally, ongoing climate change poses a significant threat by altering alpine ecosystems, potentially shifting suitable habitats to higher altitudes and leading to range contraction. Anthropogenic pressures, particularly overharvesting driven by its high medicinal demand, have further contributed to population decline and habitat fragmentation. The restricted geographical distribution of P. kurroa has important ecological and conservation implications. As a component of alpine plant communities, it contributes to ecosystem stability, soil conservation, and biodiversity maintenance. However, its limited range and declining populations necessitate urgent conservation measures. Global conservation frameworks advocated by organizations such as the International Union for Conservation of Nature emphasize the need for in situ conservation, habitat protection, and the development of sustainable cultivation practices to reduce pressure on wild populations.

Phytochemistry

Picrorhizakurroa Royle ex Benth., a high-altitude medicinal herb of the family Plantaginaceae, is widely recognized for its rich and diverse phytochemical profile. The therapeutic efficacy of the plant is primarily attributed to the presence of bioactive secondary metabolites, particularly iridoid glycosides, phenolic compounds, flavonoids, and terpenoids. These phytoconstituents play a crucial role in its pharmacological activities, especially hepatoprotective, antioxidant, anti-inflammatory, and immunomodulatory effects.

Major Phytochemical Classes

    1. Iridoid Glycosides (Principal Bioactive Constituents)

Iridoid glycosides are the most significant and characteristic compounds of P. kurroa, contributing largely to its medicinal value.

Key compounds:

    1. Picroside I
    2. Picroside II
    3. Kutkoside
    4. Picroside III

These compounds are collectively referred toas“ Kutkin”,as tan drained active fraction widely used in herbal formulations. Pharmacological Significance

      • Hepatoprotective activity
      • Anti-inflammatory effects
      • Antioxidant defense

Phenolic Compounds

Phenolic constituents contribute to the plant’s antioxidant potential and protective mechanisms against oxidative stress.

Examples:

      • Apocynin
      • Vanillicacid
      • Caffeicacid

Role

      • Free radical scavenging
      • UV protection (adaptive significance in alpine habitat)

Flavonoids

FlavonoidspresentinP.kurroaenhanceitspharmacologicalversatility.

Examples:

      • Luteolin
      • Apigenin

Biological Activities

      • Anti-inflammatory
      • Antioxidant
      • Cardioprotective

Terpenoids and Sterols

These compounds are present in minor quantities but contribute to overall therapeutic effects.

Examples:

      • Cucurbitacins
      • β-sitosterol
  1. Distribution of Phytoconstituents in Plant Parts

Table 2: Plant Part & Major Constituents

Plant Part

Major Constituents

Rhizome (major)

Picroside I & II, Kutkoside

Roots

Iridoids, phenolics

Leaves

Flavonoids, minor glycosides

Biosynthetic and Adaptive Significance

TheaccumulationofiridoidglycosidesandphenoliccompoundsinP.kurroaisclosely associated with its adaptation to high-altitude stress conditions such as:

  • High UV radiation
  • Low temperature
  • Oxidative stress These metabolites act as:
  • Protective antioxidants
  • Defense molecules against herbivores and pathogens
  1. Standardization Marker Compounds

For quality control and pharmaceutical applications, the following markers are used:

  • Picroside I
  • Picroside II

Kutkoside Analytical techniques:

  • HPLC (High Performance Liquid Chromatography)
  • HPTLC
  1. LC-MS Chemotaxonomic Significance

Iridoid glycosides serve as important chemotaxonomic markers for distinguishing P. kurroafrom related species. Their presence supports classification within the Plantaginaceae family andaids in authentication of crude drug material.

  1. Pharmacological Activities

Picrorhiza kurroa Royle ex Benth., a perennial herb of the family Plantaginaceae, has been extensively investigated for its broad spectrum of pharmacological activities. These bioactivities are primarily attributed to iridoid glycosides (picroside I, picroside II, and kutkoside), along with phenolic compounds and flavonoids. Experimental and clinical studies have demonstrated its efficacy in hepatoprotection, antioxidation, immunomodulation, anti-inflammatory, antimicrobial, and anticancer activities.

  1. Hepato protective Activity

The hepatoprotective potential of P. kurroa is its most well-established pharmacological property.

Mechanism of Action:

Stabilization of hepatocyte membranes Enhancement of antioxidant enzyme systems (SOD, catalase, glutathione) Inhibition of lipid peroxidation Modulation of liver detoxification enzymes

Experimental Evidence: Studies have shown protective effects against chemically induced liver damage (e.g., CCl₄, paracetamol toxicity), supporting its traditional use in liver disorders.

Clinical Relevance:

Liver cirrhosis Hepatitis

Drug-induced hepatotoxicity

  1. Antioxidant Activity

Theplantexhibitsstrongantioxidantpotentialduetoitsphenolicandiridoidcontent.

Mechanism: Scavenging of reactive oxygen species (ROS) Inhibition of oxidative stress pathways Protection of cellular macromolecules

Significance: This activity is crucial for preventing oxidative damage associated with chronic diseases and aging.

  1. Anti-inflammatory Activity

P. kurroa demonstrates significantanti-inflammatory effects through multiple biochemical pathways.

Mechanism:

Inhibition of pro-inflammatory cytokines (TNF-α,IL-6) Suppression of cyclooxygenase(COX) and lipoxygenase pathways Downregulation of NF-κB signaling

Application:

  • Arthritis
  • Inflammatory liver diseases Chronic inflammatory conditions
  1. Immunomodulatory Activity

The plant acts as an immunomodulator by regulating both innate and adaptive immune responses.

Mechanism:

Activation of macrophages Modulation of T-cell proliferation Enhancement of antibody production

Significance: Useful in immune- related disorders and as an adjunct in immunotherapy.

  1. Antimicrobial Activity

ExtractsofP.kurroaexhibitactivityagainstarangeofmicrobialpathogens.

Activity Spectrum:

Antibacterial (Gram-positive and Gram-negative) Antifungal

Mechanism:

Disruption of microbial cell membranes

Inhibition of enzyme systems essential for microbial survival

  1. Anticancer Activity

Emerging studies suggest anticancer potential of P. kurroa and its constituents.

Mechanism:

Induction of apoptosis Cell cycle arrest

Inhibition of tumor cell proliferation Antioxidant-mediated cyto protection 

Key Compound:

Apocynin (noted for anti-cancer and anti- inflammatory effects)

  1. Antidiabetic Activity

P. kurroahas shown promising anti-diabetic effects in experimental models.

Mechanism:

Enhancement of insulin sensitivity Reduction in blood glucose levels Protection of pancreatic β-cells

  1. Cardioprotective Activity

The plant contributes to cardio vascular health through antioxidant and lipid-lowering effects.

Mechanism:

Reduction of lipid peroxidation Improvement in lipid profile

Protection against oxidative stress-induced cardiac damage.

  1. Gastroprotective Activity

P. kurroais effective in protecting gastric mucosa.

Mechanism:

Reduction of gastric acid secretion Enhancement of mucosal defense Antioxidant protection

  1. Neuroprotective Potential

Recent studies indicate neuro protective effects.

Mechanism:

Reduction of oxidative stress in neuronal cells Anti-inflammatory action in neural tissues Protection against neurodegeneration

  1. Mechanism of Action

The pharmacological efficacy of Picrorhiza kurroa Royle ex Benth. is mediated through a complex interplay of molecular and cellular mechanisms, primarily attributed to its bioactive constituents such as picroside I, picroside II, kutkoside, and apocynin. These compounds exert multi-targeted effects by modulating oxidative stress pathways, inflammatory mediators, cellular signaling cascades, and metabolic enzymes.

  1. Antioxidant Defense Mechanism

One of the primary mechanisms underlying the therapeutic effects of P. kurroa is its potent antioxidant activity.

Molecular Actions:

Scavenging of reactive oxygen species (ROS)

Upregulation of endogenous anti-oxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase)

Inhibition of lipid peroxidation

Pathway Involved:

Activation of Nrf2 (Nuclearfactorerythroid2–relatedfactor2) signaling pathway

Outcome:

Protection of cellular macromolecules (DNA, proteins, lipids) Prevention of oxidative stress-induced tissue damage

  1. Hepatoprotective Mechanism

The hepatoprotective activity is mediated through multiple biochemical pathways.

Mechanisms:

Stabilization of hepatocyte membranes

Enhancement of detoxification n enzymes (Phase I and Phase II enzymes) Reduction of hepatic lipid peroxidation

Promotion of liver regeneration

Key Targets:

Cytochrome P450 enzyme modulation Glutathione metabolism

Outcome:

Protection against toxin-induced liver injury (e.g., CCl, paracetamol)

  1. Anti-inflammatory Mechanism

P. kurroaexerts anti-inflammatory effects by modulating inflammatory signaling pathways. Molecular Actions:

Inhibition of pro-inflammatory cytokines (TNF-α,IL-1β,IL-6) Suppression of inflammatory enzymes (COX-2, iNOS)

Key Pathway:

Down regulation of NF-κB(Nuclear Factor-kappa B)signaling

Outcome:

Reduction in inflammation and tissue damage

  1. Immunomodulatory Mechanism

The plant regulates immune responses through both stimulation and suppression depending on physiological conditions.

Mechanisms:

Activation of macrophages

Regulation of T-lymphocyte proliferation Enhancement of antibody production

Outcome:

Improved immune surveillance and response Potential use in immune-related disorders

  1. Apoptotic and Anticancer Mechanism

Certain constituents, particularly apocynin and iridoid glycosides, exhibit anticancer properties.

Mechanisms:

    • Induction of apoptosis via mitochondrial pathway
    • Activation of caspases (caspase-3, caspase-9)
    • Cell cycle arrest at G0/G1 or G2/M phase

Molecular Targets:

p53 tumor suppressor pathway

    • Bcl-2/Bax ratio modulation

Outcome:

    • Inhibition of tumor cell proliferation
  1. Antidiabetic Mechanism

P. kurroa improves glucose metabolism through multiple pathways.

Mechanisms:

  • Enhancement of insulin sensitivity
  • Protection of pancreatic β-cells from oxidative damage
  • Inhibition of gluconeogenesis

Outcome:

  • Reduction in blood glucose levels
  1. Cardioprotective Mechanism

The cardio protective effects are mediated through antioxidant and lipid-regulating mechanisms.

Mechanisms:

    • Reduction of LDL oxidation
    • Improvement in lipid profile (↓ cholesterol, ↓ triglycerides)
    • Protection against oxidative stress in cardiac tissues
  1. Gastro protective Mechanism

The plant protects gastric mucosa through cytoprotective mechanisms.

Mechanisms:

    • Inhibition of gastric acid secretion
    • Enhancement of mucosal defense factors (mucus production)
    • Antioxidant protection

Integrated Mechanistic Overview

The pharmacological actions of Picrorhiza kurroa are multi-targeted and synergistic, involving:

    • Antioxidant pathways (Nrf2 activation)
    • Anti-inflammatory pathways (NF-κB inhibition)
    • Enzymatic modulation (Cytochrome P450, antioxidant enzymes)
    • Cellular signaling pathways (apoptosis, immune regulation)
  1. Clinical Applications

Picrorhiza kurroa Royle ex Benth. has been widely utilized in traditional and modern systems of medicine for the management of various diseases, particularly liver disorders. Its clinical applications are primarily attributed to iridoid glycosides such as picroside I and II, along with other bioactive constituents that exhibit hepatoprotective, antioxidant, anti-inflammatory, and immunomodulatory properties. Increasing pharmacological and clinical evidence supports its therapeutic potential in multiple disease conditions.

    1. Liver Disorders

ThemostprominentclinicalapplicationofP.kurroaisinthetreatmentofhepatic diseases.

Indications:

      • Viralhepatitis
      • Alcoholic liver disease
      • Liver cirrhosis
      • Drug-induced hepatotoxicity

Clinical Evidence: Clinical studies have demonstrated that Kutki extracts significantly improve liver function markers such as serum bilirubin, ALT, and AST levels. The hepatoprotective action is mediated through antioxidant defense, membrane stabilization, and enhanced detoxification.

Formulations:

      • Standardized Kutkin extracts
      • Polyherbal liver tonics
    • Gastro intestinal Disorders P. kurroais traditionally used for digestive system ailments.

Clinical Uses:

  • Dyspepsia
  • Constipation
  • Indigestion

Mechanism-Based Benefit:

  • Stimulation of bile secretion
  • Improvement in digestion and metabolism
  • Gastroprotective action
    1. Respiratory Disorders

Kutki has applications in respiratory conditions due to its anti-inflammatory and immunomodulatory effects.

Indications:

      • Asthma
      • Bronchitis
      • Allergic conditions

Clinical Relevance: Reduction in air way inflammation and improved immune response contribute to symptom relief.

    1. Skin Disorders

The plant is used in dermatological conditions due to its detoxifying and anti-inflammatory properties.

Indications:

      • Eczema
      • Psoriasis
      • Allergic dermatitis
    • Metabolic Disorders P.kurroas  hows potential in managing metabolic conditions.

Applications:

  • Diabetes mellitus
  • Hyperlipidemia

Clinical Effects:

  • Reduction in blood glucose levels
  • Improvement in lipid profile
    1. Immunological Disorders

Due to its immunomodulatory properties, Kutki is used in immune-related conditions.

Applications:

      • Autoimmune disorders
      • General immune enhancement

Clinical Impact: Regulation of immune responses and enhancement of host defense mechanisms.

    1. Antioxidant and Anti-aging Applications

The antioxidant potential o fP .kurroa supports its use in preventing oxidative stress-related conditions.

Applications:

      • Aging-related disorders
      • Chronic degenerative diseases
    • Adjunct Therapy in Chronic Diseases

Kutki is often used as an adjunct in modern therapeutic regimens.

Applications:

      • Cancer supportive care
      • Chronic inflammatory diseases

Benefit: Enhances therapeutic outcomes and reduces drug-induced toxicity.

Dosage Forms Used Clinically

      • Powder (churna)
      • Capsules/tablets (standardized extracts)
      • Decoctions
      • Polyherbal formulations

Safety and Clinical Considerations

      • Generally considered safe at therapeutic doses
      • High doses may cause mild gastrointestinal discomfort
      • Requires standardization for consistent efficacy

Guidelines from organizations such as the World Health Organization emphasize quality control and safe use of herbal medicines.

  1. Toxicity and Safety

Picrorhiza kurroa Royle ex Benth., a Himalayan medicinal herb of the family Plant aginaceae, is generally regarded as safe when administered within recommended therapeutic limits. Nevertheless, a rigorous toxicological evaluation—including acute, subacute, chronic, and special toxicity studies—is essential to substantiate its safety for clinical and pharmaceutical use. Current evidence indicate safa vorable safety profile, though data from large-scale human studies remain limited.

    1. Acute Toxicity

AcutetoxicitystudiesinexperimentalmodelsreveallowtoxicityforP.kurroaextracts.

      • High LD₅₀values indicate a wide margin of safety
      • No mortality or severe behavioral abnormalities at therapeutic doses
      • Minimal changes in physiological parameters

Interpretation:

Theplantisconsideredpracticallynon-toxicinsingle-doseexposureundercontrolled conditions.

    1. Subacute and Chronic Toxicity

Repeated-dose studies provide insights into long-term safety.

Observations:

      • No significant alterations in hematological indices (Hb, RBC, WBC)
      • Liver enzymes (ALT, AST) remain within normal range
      • Renal function markers (urea, creatinine) show no adverse deviation
      • Histopathology reveals negligible tissue damage at standard doses
    • Dose-Related Adverse Effects

While generally safe, excessive or prolonged intake may lead to mild side effects.

Reported Effects:

      • Gastrointestinal disturbances (nausea, diarrhea)
      • Abdominal discomfort
      • Mild laxative action.
    • Hepatic and Renal Safety

Given its therapeutic use in hepatic disorders, organ-specific safety is critical.

      • No evidence of hepatotoxicity at therapeutic doses
      • Demonstrates hepatoprotective activity rather than toxicity
      • Renal safety is confirmed by stable biochemical markers
    • Genotoxicity and Mutagenicity

Preliminary toxicological studies suggest:

      • No significant mutagenic or genotoxic effects
      • Negative results in standard in vitro assays
    • Reproductive and Developmental Toxicity Data on reproductive safety remain insufficient. Current Understanding:
      • No conclusive evidence of teratogenic effects
      • Lack of controlled clinical studies in humans
    • Herb–Drug Interactions

Potential pharmacokinetic interactions may arise due to enzyme modulation.

Mechanistic Basis:

      • Influence on cytochrome P450 enzyme system
      • Alteration in drug metabolism and clearance

Clinical Implications: Caution is advised when co-administered with:

      • Hepatotoxic drugs
      • Antidiabetic agents
      • Immunosuppressants
    • Quality Control and Safety Standardization

Safety is strongly dependent on quality assurance and standardization.

Key Parameters:

      • Standardization using picroside I and II as marker compounds
      • Detection of adulterants and heavy metals
      • Use of analytical tools such as HPLC and LC-MS
    • Regulatory and Clinical Safety Considerations
      • Widely used in traditional systems such as Ayurveda
      • Included in herbal pharmacopoeias
      • Generally recognized as safe (GRAS-likes tatusin traditional use) However:
      • Lack of standardized clinical trials
      • Variability in extract composition across formulations

FUTURE PROSPECTS

Picrorhiza kurroa Royle ex Benth., a high-value medicinal herb of the family Plant aginaceae, has demonstrated significant pharmacological potential, particularly in hepatoprotection and antioxidant therapy. Despite extensive traditional use and promising preclinical findings, several research gaps and translational challenges remain. Addressing these limitations will be critical for the development of P. kurroa as a standardized phytopharmaceutical agent.

    1. Need for Advanced Clinical Trials

Although preclinical and limited clinical studies support the therapeutic efficacy of P. kurroa, there is a lack of:

      • Large-scale randomized controlled trials (RCTs)
      • Long-term safety and efficacy data
      • Standardized clinical protocols

FUTURE DIRECTION:

Well-designed multicentric clinical trials are essential to validate its therapeutic claims and facilitate its integration into evidence-based medicine.

CONCLUSION

The present review comprehensively highlights the botanical, ecological, phytochemical, pharmacological, and clinical significance of Picrorhiza kurroa, a high-altitude medicinal herb belonging to the family Plantaginaceae. Endemic to the alpine regions of the Himalayas, P. kurroa exhibits remarkable ecological adaptations that enable its survival under extreme environmental conditions, while also contributing to ecosystem stability and biodiversity. Phytochemical investigations reveal that the therapeutic potential of P. kurroa is primarily attributed to iridoid glycosides such as picroside I, picroside II, and kutkoside, along with phenolic compounds and flavonoids. These bioactive constituents underpin a wide range of pharmacological activities, including hepatoprotective, antioxidant, anti-inflammatory, immune modulatory, antidiabetic, and anti-cancer effects. Mechanistic studies further demonstrate that these effects are mediated through modulation of key moleculear pathways such as oxidative stress regulation, inflammatory signaling (e.g., NF-κB), and cellular defense systems. Clinically, P. kurroa has shown significant efficacy, particularly in the management of liver disorders, thereby validating its traditional use. Its applications extend to gastrointestinal, metabolic, respiratory, and dermatological conditions, highlighting its versatile it yasamulti-target therapeutic agent. Importantly, toxicological evaluations indicate a favorable safety profile with low toxicity at therapeutic doses, although caution is warranted at higher doses and in special populations due to limited clinical safety data. Despite these promising attributes, several challenges hinder its full therapeutic and commercial exploitation. These include variability in phytochemical composition, lack of standardized formulations, insufficient large-scale clinical trials, and concerns regarding sustainability due to overharvesting and habitat degradation. Addressing these limitations requires coordinated efforts in advanced research, quality standardization, and conservation strategies, supported by international frameworks such as those advocated by the World Health Organization. In conclusion, Picrorhiza kurroa represents a highly valuable medicinal plant with substantial potential for development into modern phytopharmaceuticals. Future research should focus on translational studies, clinical validation, and innovative drug delivery systems, alongside sustainable cultivation practices. The integration of traditional knowledge with contemporary scientific approaches will be pivotal in harnessing its full potential and ensuring its contribution to global healthcare systems.

REFERENCES

  1. Almeleebia, T.M., etal. (2022). Phytochemical and pharmacological insights of medicinal plants. Molecules, 27, 8316.
  2. Mehta, S., etal. (2021). Therapeutic potential of herbal drugs in liver disorders. Mini Reviews in Medicinal Chemistry, 21, 2976–2995.
  3. Raut, A., etal. (2023). Role of Ayurveda in management of liver diseases. Journal of Ayurveda and Integrative Medicine, 14, 100558.
  4. Kant, K.,etal.(2013).Evaluation of hepato protective activity of herbal extracts. Indian Journal of Pharmaceutical Sciences, 75, 324–329.
  5. Soni, D., et al. (2019). Pharmacological evaluation of plant-based compounds. Biomedicine & Pharmacotherapy, 109, 1680–1687.
  6. Banerjee, D., etal. (2008). Hepato protective activity of herbal formulations. BMC Complementary and Alternative Medicine, 8, 3.
  7. Sultan, P., etal. (2016).Botanical characterization of medicinal plants. Botanical Studies, 57, 7.
  8. Thapa, A., et al. (2022). Molecular mechanisms of plant-derived compounds.
  9. International Journal of Molecular Sciences, 23, 14090.
  10. Dong, P., etal. (2021). Drug design and phytochemicale valuation. Chemical Biology& Drug Design, 97, 341–348.
  11. Li, X., etal.(2020). Pharmacological potential of natural products. Biomedicine &   Pharmacotherapy, 130, 110421.
  12. Ghimire, S.K., McKey, D., &Aumee ruddy- Thomas, Y.(2005).Conservation of Himalayan medicinal plants. Biodiversity and Conservation, 14, 1213–1230.
  13. Nayar, M. P., & Sastry, A.R.K. (1990). Red Data Book of Indian Plants. Botanical Survey of India, Kolkata.
  14. Rawat, G.S. (2005). Alpine meadow ecosystems of the Himalaya. Environmental Conservation, 32(3), 229–240.
  15. Singh, G. B., & Rastogi, R.P. (1970). Chemical examination of Picrorhiza kurroa. Journal of Pharmaceutical Sciences, 59(3), 318–319.
  16. World Health Organization (2007). Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. WHO Press, Geneva.
  17. Nautiyal, S., & Nautiyal, M. C.(2004). Cultivation techniques of high- altitude medicinal plants. Current Science, 86(6), 807–812.
  18. Stierle, A., & Stierle, D. (2015). Bioactive secondary metabolites from natural sources.
  19. JournalofNaturalProducts,78(3),540 560. Weinges, K., Kloss, P., &Henkels, W.D. (1972). Natural products from medicinal plants. Planta Medica, 21(4), 305–313.
  20. Sood, H., et al. (2010). Extraction and analysis of picrosides from medicinal plants.
  21. Phytochemical Analysis, 21(3), 250–255.
  22. Li, J. W., & Vederas, J. C. (2009). Drug discovery and natural products. Science, 325(5937), 161–165.
  23. Saraswat, B., et al. (1999). Hepatoprotective activity of Picrorhizakurroa. Journal of Ethnopharmacology, 66(3), 263–269.
  24. Rajkumar, V., etal. (2011). Antioxidant activity of Picrorhizakurroa. Food Chemistry, 125(2), 456–461.
  25. Shukla, B., etal. (1991). Hepatoprotective effect and mechanism of herbal drugs. Planta Medica, 57(6), 525–528.

Reference

  1. Almeleebia, T.M., etal. (2022). Phytochemical and pharmacological insights of medicinal plants. Molecules, 27, 8316.
  2. Mehta, S., etal. (2021). Therapeutic potential of herbal drugs in liver disorders. Mini Reviews in Medicinal Chemistry, 21, 2976–2995.
  3. Raut, A., etal. (2023). Role of Ayurveda in management of liver diseases. Journal of Ayurveda and Integrative Medicine, 14, 100558.
  4. Kant, K.,etal.(2013).Evaluation of hepato protective activity of herbal extracts. Indian Journal of Pharmaceutical Sciences, 75, 324–329.
  5. Soni, D., et al. (2019). Pharmacological evaluation of plant-based compounds. Biomedicine & Pharmacotherapy, 109, 1680–1687.
  6. Banerjee, D., etal. (2008). Hepato protective activity of herbal formulations. BMC Complementary and Alternative Medicine, 8, 3.
  7. Sultan, P., etal. (2016).Botanical characterization of medicinal plants. Botanical Studies, 57, 7.
  8. Thapa, A., et al. (2022). Molecular mechanisms of plant-derived compounds.
  9. International Journal of Molecular Sciences, 23, 14090.
  10. Dong, P., etal. (2021). Drug design and phytochemicale valuation. Chemical Biology& Drug Design, 97, 341–348.
  11. Li, X., etal.(2020). Pharmacological potential of natural products. Biomedicine &   Pharmacotherapy, 130, 110421.
  12. Ghimire, S.K., McKey, D., &Aumee ruddy- Thomas, Y.(2005).Conservation of Himalayan medicinal plants. Biodiversity and Conservation, 14, 1213–1230.
  13. Nayar, M. P., & Sastry, A.R.K. (1990). Red Data Book of Indian Plants. Botanical Survey of India, Kolkata.
  14. Rawat, G.S. (2005). Alpine meadow ecosystems of the Himalaya. Environmental Conservation, 32(3), 229–240.
  15. Singh, G. B., & Rastogi, R.P. (1970). Chemical examination of Picrorhiza kurroa. Journal of Pharmaceutical Sciences, 59(3), 318–319.
  16. World Health Organization (2007). Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. WHO Press, Geneva.
  17. Nautiyal, S., & Nautiyal, M. C.(2004). Cultivation techniques of high- altitude medicinal plants. Current Science, 86(6), 807–812.
  18. Stierle, A., & Stierle, D. (2015). Bioactive secondary metabolites from natural sources.
  19. JournalofNaturalProducts,78(3),540 560. Weinges, K., Kloss, P., &Henkels, W.D. (1972). Natural products from medicinal plants. Planta Medica, 21(4), 305–313.
  20. Sood, H., et al. (2010). Extraction and analysis of picrosides from medicinal plants.
  21. Phytochemical Analysis, 21(3), 250–255.
  22. Li, J. W., & Vederas, J. C. (2009). Drug discovery and natural products. Science, 325(5937), 161–165.
  23. Saraswat, B., et al. (1999). Hepatoprotective activity of Picrorhizakurroa. Journal of Ethnopharmacology, 66(3), 263–269.
  24. Rajkumar, V., etal. (2011). Antioxidant activity of Picrorhizakurroa. Food Chemistry, 125(2), 456–461.
  25. Shukla, B., etal. (1991). Hepatoprotective effect and mechanism of herbal drugs. Planta Medica, 57(6), 525–528.

Photo
Minakshi Khairnar
Corresponding author

Asst. Prof., Department of Pharmaceutics, Rupesh Badhan Institute of Pharmacy, Pimpalner (MH) India

Photo
Yogeshwari Soanwane
Co-author

Rupesh Badhan institute of Pharmacy, Pimpalner, (MH) India

Photo
Rohit Thakare
Co-author

Rupesh Badhan Institute of Pharmacy, Pimpalner (MH) India

Photo
Darshan Sonawane
Co-author

Asst. Prof., Department of Pharmacology, SPH College of Pharmacy, Malegaon (MH) India

Photo
Siddhesh Nandan
Co-author

Rupesh Badhan Institute of Pharmacy, Pimpalner (MH) India

Photo
Rakesh Jadhav
Co-author

Asst. Prof., Department of Pharmaceutics, Rupesh Badhan institute of Pharmacy, Pimpalner, (MH) India

Minakshi Khairnar*, Rohit Thakare, Darshan Sonawane, Siddhesh Nandan, Rakesh Jadhav, Yogeshwari Soanwane, A Comprehensive Review on Picrorhizakurroa (Kutki): Phytochemistry, Pharmacology and Therapeutic Potential, Int. J. Med. Pharm. Sci., 2026, 2 (4), 156-171. https://doi.org/10.5281/zenodo.19622202

More related articles
Artificial Intelligence in Drug Discovery: Researc...
Vaibhav Shikhare, Vaishnavi Murhe, Gayatri Thakre, Renuka Mehasar...
Smart Nanocarriers For Targeted Drug Delivery: Rec...
Avanti Girdekar, Komal Lahase, Shital Kharat, Namrata Deshmukh, P...
General Population’s Perception and Utilization ...
Preethi V., Poovarsan S., P. Monika, ...
Kap Study on Biomedical Waste Management in A Tertiary Care Hospital in India...
Vetrivel Chezian Sengodan, Yazhini Ashok Kumar, Anees B., Divakar R., Vishnu K., ...
Herbal Drug as an Emerging Tool for Novel Drug Delivery System...
Binny Mehta, Harsh Parmar, Vraj Sorathiya, Pratham Sonkusare, ...
Zilebesiran: A Paradigm Shift in Hypertension Management Through Biannual RNA In...
C. Vaishnavidevi, Anupama Sankar , SP Santhosh Kumar, S. Abinaya, P. Abitha, J. Christy Immaculate, ...
Related Articles
test paper...
Tushar Pawar, ...
Formulation And Evaluation Of An Herbal Cream Containing Indian Jujube Seed Extr...
Himanshu Manikhedkar, Tejas Masule, Lokesh Mangle, Shailesh Patil, Jitendra More, Lina Borse, ...
Chronic Kidney Disease: A Comprehensive Review...
Utkarsh Kumar, Shashi Bhushan, Ritul Kumari, Sneha Kumari, ...
Anti-Inflammatory Effect of an Ethanolic Extract of Ficus Dalhousiae Miq Whole P...
V. Venkata Rajesham, Harish Yeleti, K. Manjeera, Ashok Morsu, Siddartha Goutham Reddy Banda, Prasann...
Artificial Intelligence in Drug Discovery: Research with Updated Ways...
Vaibhav Shikhare, Vaishnavi Murhe, Gayatri Thakre, Renuka Mehasare, Ankita Sonune, Kalyani Warade, ...
More related articles
Artificial Intelligence in Drug Discovery: Research with Updated Ways...
Vaibhav Shikhare, Vaishnavi Murhe, Gayatri Thakre, Renuka Mehasare, Ankita Sonune, Kalyani Warade, ...
Smart Nanocarriers For Targeted Drug Delivery: Recent Advances and clinical Pers...
Avanti Girdekar, Komal Lahase, Shital Kharat, Namrata Deshmukh, Payal Suradkar, Gayatri Rajguru, Gau...
Artificial Intelligence in Drug Discovery: Research with Updated Ways...
Vaibhav Shikhare, Vaishnavi Murhe, Gayatri Thakre, Renuka Mehasare, Ankita Sonune, Kalyani Warade, ...
Smart Nanocarriers For Targeted Drug Delivery: Recent Advances and clinical Pers...
Avanti Girdekar, Komal Lahase, Shital Kharat, Namrata Deshmukh, Payal Suradkar, Gayatri Rajguru, Gau...